AbbVie Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 0QCV.IL | BMY | LLY | BIIB | AMGN | PFE | |
|---|---|---|---|---|---|---|
| Market cap | 503.71B | 128.69B | 1.17T | 37.51B | 241.81B | 173.38B |
| P/E (TTM) | 57.6 | 13.9 | 43.9 | 45.1 | 27.8 | 40.0 |
| Forward P/E | — | 9.5 | 27.7 | 15.4 | 18.3 | 10.5 |
| Price/book | 38.4 | 5.8 | 34.4 | 2.0 | 20.7 | 2.0 |
| Dividend yield | 4.05% | 4.12% | 0.54% | — | 2.30% | 5.76% |
| 1-year change | +25.14% | +39.45% | +54.77% | +60.57% | +49.66% | +21.00% |
| Today | −1.75% | +3.08% | +2.83% | +5.34% | +2.04% | +1.91% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.
Latest news
All 0QCV.IL news ›AbbVie: Skyrizi And Rinvoq Keep Delivering As Oncology Gains Momentum
(NYSE:ABBV) Seeking Alpha - AbbVie is successfully transitioning beyond Humira, with Skyrizi and Rinvoq now driving over 47% of consolidated revenue and maintaining >20% growth. - Oncology prospects are improving, with strong Phase 3…
AbbVie vs. Bristol Myers Squibb: Faster Growth or Steady Revenue?
It completed the acquisition of Apogee Therapeutics to expand its dermatology and respiratory pipeline, and it secured regulatory approvals for multiple therapies in international markets. It secured accelerated regulatory approval for a…
McLaren Teams Up With AbbVie Before Formula 1 United States GP At COTA
As Formula 1 arrives in Austin, Texas for this weekend’s United States Grand Prix at COTA, McLaren has announced a partnership to help provide aid to those who live with immune-mediated disease. McLaren’s new partnership is with global…
AbbVie vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
Choosing between established dividend payers and high-growth innovators is a classic investor dilemma. This comparison pits AbbVie (ABBV +2.26%) against Vertex Pharmaceuticals (VRTX +2.53%) to determine which company offers the best…
Can This Small Biotech Enter A $4.3 Billion AbbVie Market? Rapport Shoots Higher
Allison Gatlin covers biotechnology, pharmaceuticals and medical technology. She also oversees coverage of top-performing companies for Investor's Business Daily's The New America page. Allison has worked for Investor's Business Daily…
AbbVie races into F1 as pharma companies continue push into sport
AbbVie is just one of several pharmaceutical companies to pen sponsorship deals in sport, blurring the commercial line between industries. AbbVie has continued its recent foray into sport by striking a partnership with Formula 1 (F1) team…
AbbVie reaches agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for ELAHERE® in Platinum-Resistant Ovarian Cancer
MONTREAL, Oct. 21, 2026 /CNW/ -- AbbVie is pleased to announce that negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA) have successfully been completed for ELAHERE® (mirvetuximab soravtansine for injection), and that a…
Korea approves AbbVie’s Rinvoq for severe alopecia areata and vitiligo
The Ministry of Food and Drug Safety (MFDS) has approved AbbVie's Rinvoq (upadacitinib) to treat severe alopecia areata (AA) and non-segmental vitiligo (NSV) in adults and adolescents aged 12 and older. AbbVie Korea announced the approval…
AbbVie Named Official Pharmaceutical Partner of the McLaren Mastercard Formula 1 Team, Launches AbbVie Race to Innovate to Support Immunology Community
AbbVie (NYSE: ABBV), a global pharmaceutical leader, and McLaren Racing today announced a multi-year partnership naming AbbVie an Official Pharmaceutical Partner of the McLaren Mastercard Formula 1 Team. At the center of the partnership is…
AbbVie continues sports push with McLaren; Mercedes and Stripe partner
Through the deal, the company will serve as an official pharmaceutical partner of the McLaren Formula 1 (F1) team, starting at the upcoming United States Grand Prix. AbbVie will use the partnership to promote its ‘Race to Innovate’…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
theglobeandmail.com37
-
marketscreener.com23
-
fool.com14
-
gurufocus.com14
-
tradingview.com11
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.